BN · rank #1 · 2026-06-10
UROY
NASDAQ · $453M
The exact numbers the algorithm saw.
| Composite score Z-score blend of the factors below; drives the rank. | 1.72 |
|---|---|
| Forward revenue growth Consensus forward revenue growth. | +205.8% |
| Forward net margin Consensus forward net margin. | +1.8% |
| Net margin TTM Trailing twelve month net margin. | +8.0% |
| Margin expansion Forward minus trailing net margin (percentage points). | -6.3% |
| Forward PEG Forward P/E to growth. Below 1 is cheap for the growth. | — |
| Debt / FCF Net debt relative to free cash flow. Lower is safer. | 0.00× |
| Analyst upside Spread between the consensus 12m target and the current price. | +46.2% |
| Last EPS surprise Most recent reported EPS versus consensus. | +237% |
| Market cap | $453M |
The AI research card
Independent qualitative review of each pick before the order is placed.
Summary
UROY is a pure-play uranium royalty and streaming company holding 2.86M lbs of physical U3O8 (cost US$53.15/lb vs. US$97.75/lb spot) plus royalty interests across development and producing projects, with no mining operations or debt.
Rationale
The 205.8% forward revenue growth and 236.9% last EPS surprise reflect uranium price appreciation and physical inventory revaluation, while the critical-minerals macro theme and 46.2% analyst upside align with utilities' re-entry into long-term contracting post-2023 supply squeeze.
Material risks
- 1Uranium price reversal or policy headwinds (U.S./EU nuclear regulation changes, sanctions on Kazakhstan) could rapidly deflate the US$128M unrealized gain on inventory and compress royalty economics across the portfolio.
- 2Concentration risk in counterparty projects (Cameco-operated assets, Lance, Michelin) where capex overruns, permitting delays, or technical failures would materially defer or reduce future royalty cash flows.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 3 of 3 voted to proceed.